Roche secures CE Mark approval for its automated mass spectrometry antibiotic monitoring reagents, expanding clinical ...

Roche announced Monday that it is promoting Matt Sause to oversee Roche Diagnostics. Sause currently serves as head of Roche Diagnostics’ North America Region and started his career with the company ...

Roche’s cobas BV/CV assay gains CE Mark, enabling accurate, rapid diagnosis of bacterial vaginosis and candida vaginitis.

Roche to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 GenMark’s ePlex platform delivers rapid and actionable results so clinicians can ...

Roche will leverage Signature's unique expertise in both biobanks and NGS assays to develop novel diagnostics for cancer patients "Biobanks play an important role in uncovering the cause or origin of ...

Michael Heuer, Roche Diagnostics’ region head for Europe, Middle East, Africa and Latin America, will take over until a successor is named, and will also take Digglemann’s spot on the company’s ...

Roche Diagnostics has promoted Johnny Smith to global head of communications. Smith started in the role March 1. He reports to Barbara Schädler, head of group communications for Roche, which comprises ...

Roche Holdings has been making small acquisitions to gradually bolster its diagnostics portfolio, which constitutes roughly 15% of the company’s value according to our estimates. The industry’s ...

In December 2025, Genentech, part of the Roche Group, received U.S. FDA accelerated approval for Lunsumio VELO, a subcutaneous formulation of mosunetuzumab for adults with relapsed or refractory ...

Roche has acquired Signature Diagnostics for an undisclosed price. The deal is designed to strengthen Roche’s cancer diagnostics effort with Signature’s expertise in both biobanks and next-generation ...

The event, organized by Roche Diagnostics at The Avenues Mall and sponsored by the Kuwait Diabetes Society, promotes early ...

July 21 (Reuters) - Roche's (ROG.S), opens new tab head of diagnostics, Thomas Schinecker, is to take over as group chief executive next year, replacing Severin Schwan, who will become chairman after ...